No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Rowasa is a brand of mesalamine, a drug used to treat ulcerative colitis, a type of inflammatory bowel disease. It is a topical medication, meaning it is applied directly to the affected area of the colon. It works by reducing inflammation and relieving symptoms such as abdominal pain, diarrhea, and rectal bleeding. Rowasa is available in both oral and rectal forms, and is often prescribed in combination with other medications.
Rowasa is one of the most commonly prescribed medications for ulcerative colitis, and is widely available in both generic and brand-name forms. It is typically taken on a daily basis, and is usually well-tolerated with few side effects.
In the gastrointestinal drugs market, Rowasa is a major player. It is used to treat a wide range of gastrointestinal conditions, including ulcerative colitis, Crohn's disease, and irritable bowel syndrome. It is also used to treat other conditions such as diverticulitis and proctitis.
Some of the companies in the Rowasa market include AbbVie, Allergan, AstraZeneca, GlaxoSmithKline, Merck, Pfizer, and Takeda. Show Less Read more
